Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Minasian
Vandetanib, Designed to Inhibit VEGFR2 and EGFR Signaling, Had No Clinical Activity as Monotherapy for Recurrent Ovarian Cancer and No Detectable Modulation of VEGFR2
Clinical Cancer Research
Cancer Research
Oncology
The Generalizability of NCI-sponsored Clinical Trials Accrual Amongst Women With Gynecologic Malignancies
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Related publications
Computational Model of VEGFR2 Pathway to ERK Activation and Modulation Through Receptor Trafficking
Cellular Signalling
Cell Biology
VEGF-A/VEGFR2 Signaling Network in Endothelial Cells Relevant to Angiogenesis
Journal of Cell Communication and Signaling
Biochemistry
Cell Biology
Molecular Biology
AIP1 Functions as an Endogenous Inhibitor of VEGFR2-mediated Signaling and Inflammatory Angiogenesis in Mice
Journal of Clinical Investigation
Medicine
SKLB-287, a Novel Oral Multikinase Inhibitor of EGFR and VEGFR2, Exhibits Potent Antitumor Activity in LoVo Colorectal Tumor Model
Neoplasma
Cancer Research
In Vivo Monitoring of Fetoplacental Vegfr2 Gene Activity in a Murine Pregnancy Model Using a Vegfr2-Luc Reporter Gene and Bioluminescent Imaging
Reproductive Biology and Endocrinology
Gynecology
Endocrinology
Reproductive Medicine
Developmental Biology
Obstetrics
VEGFR2-PLC 1 Axis Is Essential for Endothelial Specification of VEGFR2+ Vascular Progenitor Cells
Journal of Cell Science
Cell Biology
VEGFR2 Trafficking, Signaling and Proteolysis Is Regulated by the Ubiquitin Isopeptidase USP8
Traffic
Biochemistry
Genetics
Cell Biology
Molecular Biology
Structural Biology
Discovery of Novel Potent VEGFR2 Inhibitors Exerting Significant Antiproliferative Activity Against Cancer Cell Lines
Combination Therapy With VEGFR2 and EGFR siRNA Enhances the Antitumor Effect of Cisplatin in Non-Small Cell Lung Cancer Xenografts
Oncology Reports
Medicine
Cancer Research
Oncology
